Travere Therapeutics (TVTX) Intangibles (2013 - 2026)

Travere Therapeutics (TVTX) has 14 years of Intangibles data on file, last reported at $110.0 million in Q1 2026.

• For the quarter ending Q1 2026, Intangibles rose 5.99% year-over-year to $110.0 million; the trailing twelve-month figure through Mar 2026 stood at $110.0 million (up 5.99% YoY), and the FY2025 full-year result was $113.9 million, up 9.52% from the prior year.
• Intangibles for Q1 2026 stood at $110.0 million, down from $113.9 million in the prior quarter.
• Across five years, Intangibles topped out at $162.9 million in Q1 2023 and bottomed at $97.1 million in Q4 2022.
• The 5-year median for Intangibles is $106.9 million (2023), against an average of $119.8 million.
• The widest annual swing landed in 2024, when Intangibles sank 37.88%; it then gained 9.52% in 2025.
• A 5-year view of Intangibles shows it stood at $97.1 million in 2022, then climbed by 7.59% to $104.4 million in 2023, then slipped by 0.45% to $104.0 million in 2024, then advanced by 9.52% to $113.9 million in 2025, then fell by 3.36% to $110.0 million in 2026.
• The last three Intangibles figures came in at $110.0 million (Q1 2026), $113.9 million (Q4 2025), and $109.4 million (Q3 2025), per Business Quant data.

Peer Comparison